FGF2 and Alzheimer disease: This, however, does not simply imply that FGF2 replenishment confers therapeutic benefits for AD, since it also promotes aOPC proliferation, thereby inhibiting oligodendrocyte differentiation (Fig. 1d, f) and likely disturbing normal myelination.